2026 ICD-10-CM Diagnosis Code D68.312Antiphospholipid antibody with hemorrhagic disorder

ICD-10-CM CodesD50–D89D65-D69D68

ICD-10-CM D68.312
CMSSource: CMS FY 2026 ICD-10-CM dataset · Effective Oct 1, 2025 – Sep 30, 2026

D68.312 is a billable ICD-10-CM diagnosis code for antiphospholipid antibody with hemorrhagic disorder. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026) and groups to MS-DRG 814 through 816. In AHRQ's Clinical Classifications Software (CCSR), this diagnosis falls under Coagulation and hemorrhagic disorders.

Code Identity

ICD-10-CM Code
D68.312
Billable Status
Yes — Valid for Submission
Code Describes
Antiphospholipid antibody with hemorrhagic disorder
Short Description
Antiphospholipid antibody with hemorrhagic disorder
Same as the full description in the CMS dataset.
Parent Code
Hemorrhagic disorder due to intrinsic circulating anticoagulants, antibodies, or inhibitors

Code Classification

ChapterD50–D89Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
SectionD65-D69Coagulation defects, purpura and other hemorrhagic conditions
CategoryD68Other coagulation defects
This CodeD68.312Antiphospholipid antibody with hemorrhagic disorder

Tabular List NotesGuidance

Coding notes and annotation back-references applicable to this code.

Inclusion Terms

  • Lupus anticoagulant (LAC) with hemorrhagic disorder
  • Systemic lupus erythematosus SLE inhibitor with hemorrhagic disorder

Type 1 Excludes

  • antiphospholipid antibody, finding without diagnosis R76.0
  • lupus anticoagulant LAC finding without diagnosis R76.0
  • systemic lupus erythematosus SLE inhibitor finding without diagnosis R76.0

Type 2 Excludes

  • antiphospholipid antibody syndrome D68.61
  • antiphospholipid antibody with hypercoagulable state D68.61
  • lupus anticoagulant LAC with hypercoagulable state D68.62
  • systemic lupus erythematosus SLE inhibitor with hypercoagulable state D68.62

Index to Diseases and InjuriesGuidance

External Cause of Injuries IndexGuidance

References for this code in the External Cause of Injuries Index.

    • Antibody
      • anticardiolipin
        • with
          • hemorrhagic disorder
    • Antibody
      • antiphosphatidylglycerol
        • with
          • hemorrhagic disorder
    • Antibody
      • antiphosphatidylinositol
        • with
          • hemorrhagic disorder
    • Antibody
      • antiphosphatidylserine
        • with
          • hemorrhagic disorder
    • Antibody
      • antiphospholipid
        • with
          • hemorrhagic disorder
    • Antiphospholipid
      • antibody
        • with hemorrhagic disorder
    • Lupus
      • anticoagulant
        • with
          • hemorrhagic disorder
    • Lupus
      • erythematosus (discoid) (local)
        • systemic
          • inhibitor (presence of)
            • with
              • hemorrhagic disorder

Clinical ClassificationClinical

AHRQ’s CCSR groups this code into broader clinical categories.

CCSR BLD006
Coagulation and hemorrhagic disorders
Default principal diagnosis: inpatient Yes · outpatient Yes

Patient EducationClinical

Autoimmune Diseases

Your immune system protects you from disease and infection by attacking germs that get into your body, such as viruses and bacteria. Your immune system can tell that the germs aren't part of you, so it destroys them. If you have an autoimmune disease, your immune system attacks the healthy cells of your organs and tissues by mistake.

The full article covers:

  • What are autoimmune diseases?
  • What causes autoimmune diseases?
  • Who is at risk for autoimmune diseases?
  • What are the symptoms of autoimmune diseases?
  • How are autoimmune diseases diagnosed?
  • What are the treatments for autoimmune diseases?

Read the full article at MedlinePlus

Courtesy of MedlinePlus, a service of the U.S. National Library of Medicine.

Convert D68.312 to ICD-9-CMHistory

The closest ICD-9-CM equivalents under the General Equivalence Mappings.

ICD-9-CM
286.53 Antiphospholipid w hemor
Exact Match The mapping is direct, with no qualifiers.

Code HistoryHistory

FY 2016AddedAdded to the ICD-10-CM code setEffective October 1, 2015, the first year of ICD-10-CM.
FY 2017–2025No changes
FY 2026CurrentCurrent code set, no changesEffective October 1, 2025 through September 30, 2026.

Questions About D68.312Overview

Is D68.312 a billable code?

Yes. This is a billable ICD-10-CM code, specific enough to report antiphospholipid antibody with hemorrhagic disorder on HIPAA-covered claims from October 1, 2025 through September 30, 2026.

What MS-DRG does D68.312 group to?

When antiphospholipid antibody with hemorrhagic disorder is the principal diagnosis on an inpatient stay, it groups to MS-DRG 814, 815, 816, with relative weights from 0.6320 to 2.1267 depending on complications. Higher weights mean higher Medicare reimbursement.

What is the ICD-9 equivalent of D68.312?

Under the General Equivalence Mappings, antiphospholipid antibody with hemorrhagic disorder converts to ICD-9-CM 286.53 (antiphospholipid w hemor). The mapping is a direct match.

Footnotes

[1] Chronic - a chronic condition code indicates a condition lasting 12 months or longer and its effect on the patient based on one or both of the following criteria:

  • The condition results in the need for ongoing intervention with medical products,treatment, services, and special equipment
  • The condition places limitations on self-care, independent living, and social interactions.